These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4156590)

  • 1. Drugs and appetite.
    Pawan GL
    Proc Nutr Soc; 1974 Dec; 33(3):239-44. PubMed ID: 4156590
    [No Abstract]   [Full Text] [Related]  

  • 2. Appetite regulation by drugs and endogenous substances.
    Sullivan AC; Triscari J; Cheng L
    Curr Concepts Nutr; 1983; 12():139-67. PubMed ID: 6303697
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut hormones in the control of appetite.
    Murphy KG; Bloom SR
    Exp Physiol; 2004 Sep; 89(5):507-16. PubMed ID: 15184357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and appetite.
    Anderson J
    Practitioner; 1974 Apr; 212(1270 Spec No):536-44. PubMed ID: 4609077
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of ghrelin in the regulation of appetite in children.
    Savastio S; Bellone S; Baldelli R; Ferraris M; Lapidari A; Zanetta F; Sogni S; Petri A; Bona G
    Minerva Pediatr; 2006 Feb; 58(1):21-6. PubMed ID: 16541004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of appetite regulation.
    Barrett AM
    Proc Nutr Soc; 1978 Sep; 37(2):193-9. PubMed ID: 704614
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological approaches to feeding behaviour and eating disorders.
    Willner P; Bergman J; Vanderschuren L
    Behav Pharmacol; 2012 Sep; 23(5-6):439-40. PubMed ID: 22854303
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chronic amphetamine on the appetitive and consummatory phases of feeding.
    Wolgin DL
    Appetite; 2002 Jun; 38(3):221-3. PubMed ID: 12071688
    [No Abstract]   [Full Text] [Related]  

  • 10. Systems and interactions: an approach to the pharmacology of eating and hunger.
    Blundell JE
    Res Publ Assoc Res Nerv Ment Dis; 1984; 62():39-65. PubMed ID: 6695116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacologic treatment of obesity].
    Villanueva L; Carruba MO; Peñalva A; Pandiella A; Díaz Y; Casanueva FF; Cabezas Cerrato J; Fernández-Cruz A
    Rev Clin Esp; 1986 Oct; 179(6):317-22. PubMed ID: 3797737
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of the biguanides in the treatment of obesity].
    Bittnerová H; Masek J; Rath R
    Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
    [No Abstract]   [Full Text] [Related]  

  • 13. The anorexigenic effects of amphetamine in mice treated with aurothioglucose.
    Mogenson GJ; Cinnamon AD; Stevenson JA
    Can J Physiol Pharmacol; 1967 May; 45(3):564-7. PubMed ID: 6035177
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroregulators and feeding: implications for the pharmacological manipulation of hunger and appetite.
    Blundell JE
    Rev Pure Appl Pharmacol Sci; 1982; 3(4):381-462. PubMed ID: 6137866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of a new appetite stimulant. Analysis of 35 cases].
    Blasi R; Uratane L; Verone O; Cohen A
    Hospital (Rio J); 1968 Oct; 74(4):1279-84. PubMed ID: 4387601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological activity of the optical isomers of sydnocarb].
    Al'tshuler RA; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(4):345-9. PubMed ID: 7439363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Buclizine as an appetite stimulant. Clinical, experimental and toxicological studies].
    Higa J; Micelli I; Astolfi E
    Prensa Med Argent; 1969 Aug; 56(23):1129-33. PubMed ID: 5266378
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of cholecystokinin in appetite control.
    Lamers CB; Lieverse RJ; Masclee AA; Jansen JB
    Br J Hosp Med; 1995 Feb 1-14; 53(3):113. PubMed ID: 7728311
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
    Hsieh YS; Yang SF; Kuo DY
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology: does gut hormone PYY3-36 decrease food intake in rodents?
    Tschöp M; Castañeda TR; Joost HG; Thöne-Reineke C; Ortmann S; Klaus S; Hagan MM; Chandler PC; Oswald KD; Benoit SC; Seeley RJ; Kinzig KP; Moran TH; Beck-sickinger AG; Koglin N; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Schindler M; Arndt K; Rudolf K; Mark M; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Craney S; Flora D; Smiley D; Heiman ML
    Nature; 2004 Jul; 430(6996):1 p following 165; discussion 2 p following 165. PubMed ID: 15243972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.